In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Keymed Biosciences Inc.

http://www.keymedbio.com/

Latest From Keymed Biosciences Inc.

Chinese Domestic Alliances Focus On China-Only Rights As Confidence Grows

Confidence in growing in-house commercial capabilities has recently prompted several Chinese pharmas, including Simcere and 3SBio, to focus on obtaining domestic rights to novel drug assets developed by other China-based biotechs, rather than pursuing international deals.

China Deals

ADCs Propel China Oncology Innovation But PD-1s Still Cast Shadow

Among the newer modalities to tackle cancer, antibody-drug conjugates are fast emerging to rival targeted antibodies and China is fast emerging as a world class source of innovation in the field, as evidenced by a string of recent deals.

Asia Pacific China

Watch Out Sanofi! Chinese Fast-Follower Emerges With Dupixent Rival

Keymed’s anti-IL-4Rα antibody stapokibart has delivered compelling top-line efficacy and safety results in a China Phase III study, which could help it challenge Sanofi/Regeneron’s Dupixent in the country.

China Clinical Trials

ADCs Propel China Oncology Innovation But PD-1s Still Cast Shadow

Among the newer modalities to tackle cancer, antibody-drug conjugates are fast emerging to rival targeted antibodies and China is fast emerging as a world class source of innovation in the field, as evidenced by a string of recent deals.

Deals Research & Development
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Keymed Bioscience (Chengdu) Co., Ltd.
    • Chengdu Keymed
    • 2Health Biosciences Inc.
UsernamePublicRestriction

Register